Atlas Trials

Efficacy of Different COVID-19 Vaccine Combinations in Inducing Long-term Humoral Immunity [PRIBIVAC]

Clinical trial NCT05142319 · COMPLETED

Trial details

NCT number
NCT05142319
Sponsor
Tan Tock Seng Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
COVID-19
Start date
2021-10-12
Primary completion
2023-06-01
Enrollment
326

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.